Veriheal

FEBRUARY 11, 2021

The objective of the survey published in December 2020 explored “ the effect that medical cannabis has on prescription opioid medication usage for the treatment of chronic pain at three medical cannabis practice sites ”. The Effect of Medical Cannabis on Prescription Opioids.

Chronic Pain 93

Chronic Pain Patients Clinical Trials Treatment 93

Veriheal

NOVEMBER 17, 2020

According to the Ohio State Medical Marijuana website, the petition will not be considered if received after December 31, 2020, if it seeks to add a broad category of diseases or conditions, or if the condition is one that has been previously reviewed by the board and rejected unless new scientific research that supports the request is offered.

Conditions 98

Conditions Research and Development Pharmaceutical Clinical Trials 98

LifeCannMD

MAY 27, 2025

This system is constantly working behind the scenes, keeping everything balanced: How excited your brain cells get Your sleep patterns Mood regulation Pain levels Even your appetite Pretty amazing, right? I’ve had parents tell me they can finally sleep at night knowing their child is protected but completely clear-headed.

CBD 52

CBD Oil Epilepsy Sleep 52

Cannabis Law Report

JULY 8, 2021

cbdMD began its first phase of research in the Fall of 2020, with its first in vivo animal study and clinical trials. ’s Annual Report on Form 10-K for the fiscal year ended September 30, 2020 as filed with the Securities and Exchange Commission (the “SEC”) on December 22, 2020, Item 1A.

Research and Development 85

Research and Development Pets Cannabinoids eCommerce 85

Cannabis Law Report

MAY 10, 2022

This is despite a limited number of high-quality clinical trials investigating the drug’s efficacy for this condition. Using data from the Therapeutic Goods Administration (TGA) – Australia’s Special Access Scheme B, the researchers found the other two top reasons for prescriptions were pain and sleep disorders.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

NOVEMBER 13, 2019

This ground-breaking trial has full parliamentary support, and will be evaluated in mid-2020. Croome’s investments in the Phytomedicine Institute at Harvard University and a major Canadian university are developing medical tests and formulations in anti-inflammatory medicine, sleep-aid, and nerve control. Arundati Dandapani.

Clinical Trials 78

Clinical Trials Research and Development Cultivation Patients 78

Cannabis Law Report

MAY 10, 2022

Anxiety and sleep disorders were some reasons given for prescriptions despite lack of evidence for cannabis treatment, researchers find. of prescriptions were for sleep disorders. The data also shows that prior to 2020, people between 45 and 52 years old had the highest incidence of prescriptions. The Guardian writes.

Medicine 52

Medicine Clinical Trials Data Sleep 52

The Cannigma

JUNE 24, 2021

For instance when it comes to pain relief, THC and CBD have shown to be safer than opioids; and for anti-anxiety and sleep aids, CBD does not appear to be habit-forming like benzodiazepines. Getting a good night’s sleep is a crucial step in leading a healthier lifestyle, and the benefits can be felt throughout the day.

CBD 101

CBD Microdosing Edibles Sleep 101

Cannabis Law Report

SEPTEMBER 9, 2021

Based on the sources, the marijuana segment accounted for the highest revenue share in 2020 and is expected to exhibit the fastest growth rate during the forecast period. The medical end-use segment dominated the market in 2020 and will retain the leading position during the forecast years. Chapter 2 Executive Summary. Market Dynamics.

Recreational 73

Recreational Hemp THC Legalization 73

Cannabis Law Report

OCTOBER 12, 2021

Diamandis joins Radicle Science as the healthtech company accelerates growth with industry veteran Sheldon Borkin PhD as CTO, the launch of a first of its kind real-world sleep study, and updates on significant milestones this year. Radicle Real World Sleep results will be announced in early 2022. “We

Clinical Trials 40

Clinical Trials Research and Development Sleep Cannabinoids 40

Cannabis Law Report

FEBRUARY 3, 2022

Together with its wide network of research partners, MediCane is executing clinical programs to develop cannabis-based drugs with two leading therapeutic areas – Behavioral and Psychological Symptoms of Dementia (BPSD) and sleep disorders. The company launched its manufacturing facility in Kfar Saba in 2020.

Clinical Trials 40

Clinical Trials Research and Development Packaging Oil 40

Cannabis Law Report

OCTOBER 29, 2021

The highlights for the quarter are: As previously disclosed, on September 7, 2021, the Company announced the completion of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”) based investigational new drug, IGC-AD1, intended to alleviate certain symptoms of individuals who have Alzheimer’s disease.

Clinical Trials 40

Clinical Trials Research and Development Data Business 40

The Joint Blog

FEBRUARY 24, 2021

The effects were so promising that Parkinson’s UK began funding for the worlds first clinical trial. This trial would be used to assess whether or not CBD could treat the psychosis symptoms of Parkinson’s. This trial was to take 3.5 However, they also stated that there have been promising effects noted in lab studies.

Treatment 55

Treatment Clinical Trials Collective Patients 55

CannaMD

AUGUST 26, 2020

Note: No human studies were found (with the exception of one clinical trial that was ongoing and therefore not selected); all studies focused on animals (i.e., In 2020, researchers demonstrated that CBD was able to block cocaine-enhanced brain-stimulation reward. mice/rats). But not to worry.

Therapy 98

Therapy CBD Research and Development Treatment 98

Cannabis Law Report

NOVEMBER 24, 2021

The Office of Drug Control (ODC) (ODC 2020 ), alongside the Therapeutic Goods Administration (TGA), regulates the production of cannabis and cannabis products. The outlier is ACT which in 2020 legalised cannabis for recreational use. Less frequent were references to multiple sclerosis, anxiety and depression, sleep, and HIV.

Research and Development 52

Research and Development Medicine Access Media 52

Veriheal

JULY 12, 2021

A 2020 study reported that the top conditions reported amongst veterans include chronic pain , sleep problems , anxiety , and depression. The study reported that cannabis was associated with a reduction in PTSD-related nightmares as well as contributing to improved sleep. What Is The Latest Research for Veterans and PTSD?

Treatment 105

Treatment Sleep Clinical Trials Data 105

Cannabis Law Report

JUNE 4, 2021

D8 may well assist with relaxation and sleep. The slight “high” seems to be part of the appeal but the relaxation and sleep benefits also carry broad appeal as well. They also sleep better and aren’t as bothered by “Musculo-Skeletal Discomfort”. Do you think there would be such a fuss about 8 if it didn’t get people “high”? .

Research and Development 105

Research and Development Seed-To-Sale Cannabinoids THC 105

Healer

MARCH 26, 2021

It’s estimated that 2020 spending was about $48 million. . Funding for all research into cannabis also has increased, from $111 million in 2015 to an estimated $196 million in 2020. . The researchers stressed the need for large, well-designed clinical trials. Spending on such studies has more than doubled since then.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Cannabis Law Report

DECEMBER 30, 2019

After this historically successful year, we expect to see public and political support continue to increase in 2020 as more and more states implement sensible cannabis regulatory policies. A House floor vote on HR 3884 is anticipated in 2020. FY 2020 Successful House Appropriations Advancements. Erik Altieri.

Legislation 45

Legislation Patients Access Banking 45

SMPL

MAY 26, 2020

But the CBD landscape of 2020 looks nothing like what the activists and scientists intended. fast-tracked clinical trials of GW Pharmaceuticals’ 98 percent CBD drug, Epidiolex. There haven’t been enough clinical trials and there never will be,” said Mr. Clarke, the cannabis seed collector.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

The Cannigma

MARCH 12, 2021

We’re not going to get over the fact that there’s not the same sort of clinical trial and that type of evidence for cannabis and cannabis treatments in the very near future for various reasons. There’s the one drug, one target, cannabis is multiple active ingredients and acts on multiple targets in the body.

Legalization 132

Legalization Patients Education Dispensary 132

The Cannigma

JULY 20, 2021

A review based on seven different clinical trials concluded that “Silexan is a safe and effective treatment in anxiety disorders” 6. According to a 2020 study performed on animal models, “BCP may be effective in treating depression and stress related mental illnesses. Helping anxiety. Best strains for stress.

Strains 145

Strains Terpenes Concentrates THC 145

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Published in late 2020, Brian has since appeared on dozens of media outlets, including Joe Rogan’s podcast, CNN, and Vice.

Research and Development 51

Research and Development Medicine Pharmaceutical Treatment 51